Ethyl 4-amino-6-chloropyridine-3-carboxylate, 95.0%, 25g

3-Bromo-2-chloro-4-ethoxypyridine, 97%, 5g

2-Bromo-5-trifluoromethylbenzothiazole, 97%, 10g

4-Oxo-4-piperidin-1-yl-butyric acid, 98.0%, 1g

(2E)-3-[4-(benzyloxy)phenyl]-1-(2,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

2-Amino-4,5-dibromobenzoic acid, 95.0%, 100mg

(3,5-Difluoropyridin-2-yl)methanamine dihydrochloride, 95.0%, 1g

4-[5-(2,2,2-Trifluoroethyl)-1,2,4-oxadiazol-3-yl]piperidine hydrochloride, 1g

(R)-1-(4-PYRIDINYL)ETHYLAMINE DIHYDROCHLORIDE, 97.0%, 1g

Boc-D-Phe(4-cn)-OH, 95%, 25g

5-Chloro-2,4-difluorobenzyl amine, 95.0%, 1g

3-(Difluoromethyl)-2-oxopiperidine-3-carboxamide, 95.0%, 1g

Objetivo fase plan corregida al infinito S100x/1,25. Distancia de trabajo 0,18 mm